Roxanne Palmer
Roxanne Palmer is interning at Xconomy's Boston office this summer. She is currently pursuing a master's degree in science and medical Journalism at Boston University after graduating from Brown in 2008 with a degree in English. Her thesis was on Herman Melville's Civil War poetry.
When not chronicling the ups and downs of Boston's tech industry, Roxanne enjoys drawing, swimming, and birdwatching.
Follow her on Twitter at http://twitter.com/roxannedpalmer, or email her at rpalmer@xconomy.com.
Recent posts
[Updated with Bloomberg comment at 12:55 pm Eastern]
Tensions at the Biogen Idec annual shareholders meeting are palpable. Representatives from billionaire investor Carl Icahn have twice called for the polls to... Read more »
Newton, MA-based Clinical Data (NASDAQ:CLDA), announced positive results from the second Phase III trial of its antidepressant, vilazodone. In a study of 481 patients, the drug reduced depression symptoms,... Read more »
Soon, you really won’t need a weatherman to know which way the wind is blowing in Massachusetts (or one part of the state, anyway)—all you’ll have to do is look for... Read more »
When Ryan Damico was an undergraduate at MIT, he attended a training session at the university’s library. Ostensibly, the students were being taught how to properly organize sources for research papers.... Read more »
Waltham, MA-based Proteon Therapeutics, which specializes in drug development for kidney and vascular diseases, announced today that it has completed a second closing for its Series B equity financing round.... Read more »
In the 1960s, there weren’t many role models a little black girl interested in science could relate to. As a child, Evelynn Hammonds, who would become the first black female Dean... Read more »
Yet another Boston-area innovation institution has been hit by the recession: the summer internship. Jackie Wilbur, the director of the Career Development Office at MIT’s Sloan School of Management, says that... Read more »
Evergreen Solar (NASDAQ:ESLR), a manufacturer of low-cost silicon-based solar power products, will offer $60 million in common stock, the Marlboro, MA-based company announced today. Proceeds from the offering... Read more »
Two major pieces of news from Elixir Pharmaceuticals today: first, the Cambridge, MA-based drug maker has just completed a $12 million round of equity financing led by MPM Capital, which joins... Read more »
Signing up for XSITE 2009, Xconomy’s Summit on Innovation, Technology, and Entrepreneurship on June 24, ensures your access to the biggest showcase of New England technological ingenuity on either side of... Read more »
Knome, a personal genomics startups located in Cambridge, MA, announced today the launch of its newest product, a partial genome sequencing package called KnomeSELECT. The service will cost $24,500 for... Read more »
The climate in Boston this week was neither steamy nor stormy. Likewise, the week in deals was a little bit hot and a little bit cold —with not much on either... Read more »
